LIMAX
Price
$6.68
Change
+$0.02 (+0.30%)
Updated
Dec 24 closing price
Net Assets
25M
RGEBX
Price
$77.54
Change
+$0.22 (+0.28%)
Updated
Dec 24 closing price
Net Assets
338.91B
Interact to see
Advertisement

LIMAX vs RGEBX

Header iconLIMAX vs RGEBX Comparison
Open Charts LIMAX vs RGEBXBanner chart's image
Cromwell Tran Sustainable Focus Investor
Price$6.68
Change+$0.02 (+0.30%)
VolumeN/A
Net Assets25M
American Funds Growth Fund of Amer R2E
Price$77.54
Change+$0.22 (+0.28%)
VolumeN/A
Net Assets338.91B
LIMAX vs RGEBX Comparison Chart in %
View a ticker or compare two or three
VS
LIMAX vs. RGEBX commentary
Dec 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LIMAX is a Hold and RGEBX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RGEBX has more cash in the bank: 339B vs. LIMAX (25M). LIMAX (0.00) and RGEBX (0.00) have matching dividends . LIMAX was incepted earlier than RGEBX: LIMAX (18 years) vs RGEBX (11 years). LIMAX (1.88) is less costly to investors than RGEBX (1.08). LIMAX is a more actively managed with annual turnover of: 37.00 vs. RGEBX (32.00). RGEBX has a lower initial minimum investment than LIMAX: RGEBX (250) vs LIMAX (2000). RGEBX annual gain was more profitable for investors over the last year : 5.18 vs. LIMAX (-6.96). RGEBX return over 5 years is better than : 19.19 vs. LIMAX (-17.94).
LIMAXRGEBXLIMAX / RGEBX
Total Expense Ratio1.351.08125%
Annual Report Gross Expense Ratio1.881.08174%
Fund Existence18 years11 years-
Gain YTD-4.0238.539-47%
Front LoadN/AN/A-
Min. Initial Investment2000250800%
Min. Initial Investment IRAN/AN/A-
Net Assets25M339B0%
Annual Yield % from dividends0.000.00-
Returns for 1 year-6.965.18-134%
Returns for 3 years39.4662.2763%
Returns for 5 years-17.9419.19-93%
Returns for 10 years-40.5788.81-46%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AZ6.510.46
+7.60%
A2Z Cust2Mate Solutions Corp
ARDT8.970.16
+1.82%
Ardent Health Inc
HBIO0.73N/A
+0.64%
Harvard Bioscience
BUD63.83-0.12
-0.19%
Anheuser-Busch INBEV SA/NV
KEX110.84-0.54
-0.48%
Kirby Corp